Grant: Fellowship: Priority Announcement - Kidney Disease
Direct Payment
$75,000.00
Identification and characterization of monogenic causes of hereditary kidney disease for the development of novel drug therapies.
FY 2016-17
Summary
Chronic kidney disease greatly affects the health of the general population. Nephronophthisis is the most frequently inherited cause of chronic kidney disease in children and young. The term nephronophthisis refers to the wasting away (from Greek, phthisis) of the smallest unit of the kidney, the nephron. Affected children are typically born to unaffected parents and clinical symptoms, such as increased thirst or urination, are often mild and may go unnoticed. When the child or young adult finally comes to their doctor's attention, the kidney damage cannot be undone. Once kidney function is lost, the treatment options are either hemodialysis (which filters toxins out of the blood) or kidney transplant. Both options are associated with significant health risks and are very labour and cost intensive. This highlights the need for early identification of at-risk individuals and the need for the development of new treatment options. Inherited changes in a number of genes are known to cause nephronophthisis. Dr. Friedhelm Hildebrandt at the Boston Children's Hospital is a world leader at identifying new genes which cause kidney disease when changed. The goal of my project in his laboratory is firstly, to better understand the role of a recently identified kidney-disease gene discovered in a family from Montreal. I will use Dr. Hildebrandt's database of >1,500 families with unsolved cases of kidney disease to screen for other families with changes in this gene. To do this, we will use state-of-the-art technology, such as whole-exome capture and next-generation sequencing. Both methods allow us to look at a vast amount of genes in an efficient manner. I will then use well-known animal models of nephronophthisis, such as zebrafish, to further detail how this gene causes kidney disease and use these animal models to screen for new therapies. This work will hopefully lead to the development of new treatment options for genetic forms of kidney disease.
Department
Program
Fellowship: Priority Announcement - Kidney Disease
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
363819
Name
Kitzler Thomas M
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Partnername
Kidney Foundation of Canada
Instname2
Genetics
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Identification and characterization of monogenic causes of hereditary kidney disease for the development of novel drug therapies.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Fellowship: Priority Announcement - Kidney Disease
Keyworddelim
Drug Discovery; Hereditary Kidney Disease; Nephrology; Nephronophthisis; Nephronophthisis Related Ciliopathies; Whole Exome Sequencing; Zebrafish Animal Models
Abstract
Chronic kidney disease greatly affects the health of the general population. Nephronophthisis is the most frequently inherited cause of chronic kidney disease in children and young. The term nephronophthisis refers to the wasting away (from Greek, phthisis) of the smallest unit of the kidney, the nephron. Affected children are typically born to unaffected parents and clinical symptoms, such as increased thirst or urination, are often mild and may go unnoticed. When the child or young adult finally comes to their doctor's attention, the kidney damage cannot be undone. Once kidney function is lost, the treatment options are either hemodialysis (which filters toxins out of the blood) or kidney transplant. Both options are associated with significant health risks and are very labour and cost intensive. This highlights the need for early identification of at-risk individuals and the need for the development of new treatment options. Inherited changes in a number of genes are known to cause nephronophthisis. Dr. Friedhelm Hildebrandt at the Boston Children's Hospital is a world leader at identifying new genes which cause kidney disease when changed. The goal of my project in his laboratory is firstly, to better understand the role of a recently identified kidney-disease gene discovered in a family from Montreal. I will use Dr. Hildebrandt's database of >1,500 families with unsolved cases of kidney disease to screen for other families with changes in this gene. To do this, we will use state-of-the-art technology, such as whole-exome capture and next-generation sequencing. Both methods allow us to look at a vast amount of genes in an efficient manner. I will then use well-known animal models of nephronophthisis, such as zebrafish, to further detail how this gene causes kidney disease and use these animal models to screen for new therapies. This work will hopefully lead to the development of new treatment options for genetic forms of kidney disease.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kitzler, Thomas M
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $75,000~ $0~